Connect with top gaming leaders in Los Angeles at GamesBeat Summit 2023 this May 22-23. Register here.
Lumiata, a company providing AI-powered predictive analytics for managing health care costs, has raised $14 million. The company says it will use the funds to scale its platform and invest in customer acquisition ahead of the opening of an office in Guadalajara, Mexico in 2021.
As many as 3.5 million adult hospital stays in 2017 — to the tune of nearly $34 billion — were considered potentially preventable, according to the Agency for Healthcare Research and Quality. The preventable stays represented nearly 13% of all hospital stays and almost 9% of all costs, excluding obstetrics.
Lumiata’s apps and data science tools aim to solve this by enabling a partnership with payers, providers, and digital health companies to address underwriting, actuarial, care management, and pharmacological analytics challenges. The platform combines health care datasets — from sources ranging from standardized codes to handwritten notes — into a single dataset. Patients’ data is ingested, cleansed, and organized into a unified record and enriched with annotations that make it ready for machine learning.
To deliver insights, Lumiata claims to draw from health care data, medical knowledge, and clinical intellectual property from 120 million patient records, 35,000 physician-curated hours, lab results, medical billing codes, insurance claims, and 50 million articles from the free biomedical research search engine PubMed. The platform can identify patients likely to develop one of over 20 diseases within 12 months; stratify and predict which patients are candidates for remote care or intervention; and anticipate which patients are at risk of hospitalization, admission, and readmission. Beyond this, Lumiata can calculate health care resource needs and associated costs, as well as disease spread by region and community hospital system.
Join us in San Francisco on July 11-12, where top executives will share how they have integrated and optimized AI investments for success and avoided common pitfalls.
Lumiata, whose platform integrates with existing systems and informs physicians of patients’ comorbidities, prior hospitalizations, and more, says it performs autonomous quality checks on the datasets in its platform to ensure they remain up to date. Moreover, the company claims its over 100 pretrained models are 5% to 35% more accurate than leading prediction models.
“In many instances, Lumiata has identified hundreds of millions of dollars in risks on their customers’ books that they were previously unaware they had,” a spokesperson told VentureBeat via email. “Customers are also able to reduce costs and provide more responsible and responsive health care to their members. Deploying Lumiata is a low- to no-code process. It is cloud-based, fully scalable, and integrates with existing systems through APIs.”
Defy.vc and AllegisNL Capital co-led Lumiata’s series B round announced today. Khosla Ventures and Blue Venture Fund also participated, bringing the company’s total raised to over $50 million.
Lumiata competes with a number of companies in the health care predictive analytics space, which is expected to be worth $19.5 billion by 2025, according to a report from Grand View Research. ClosedLoop.ai, a health care data science startup specializing in AI and automation, recently raised $11 million. There’s also KenSci, which aims to help health care practitioners cut costs by algorithmically identifying contributing clinical and financial factors. Cardinal Analytx Solutions develops predictive analytics software for health care payers and providers, while LeanTaaS taps data science to improve health care provider performance in the area of resource utilization. And Medopad employs a combination of machine learning and big data analyses to help predict and manage chronic diseases.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.